Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by canadapieton Nov 26, 2019 1:00pm

96 Views

Post# 30394043

RE:US shorts

If an Amarican investor sees they have 40 M cash and they have 5O M in debt........., and they see that of the 76 M shares there is a free float of 75 M ....... they think a decline in the share price is obvious and they short it!!!!! The investors know that at some near point in the future they have to do an offering, otherwise hey wouldn't have come to the nasdaq.

"Hope" is not the word they use and work with in the States......

Bullboard Posts

Anaergia expands relationship with PepsiCo